Cardiovascular Drugs and Therapy Celebrates its 30th Year with the Appointment of a New Co-Editor-in-Chief Willem J. Remme EDITORIAL 30 March 2016 Pages: 109 - 110
Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia Rong LiuHong ShenMeng Wei ORIGINAL ARTICLE 09 December 2015 Pages: 111 - 118
A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats Pietro Lo GiudiceMario BonominiArduino Arduini ORIGINAL ARTICLE 02 February 2016 Pages: 119 - 127
Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury Jinqiao QianHongmei ChenYumei Ye ORIGINAL ARTICLE 10 February 2016 Pages: 129 - 141
Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy Monica VerdoiaPatrizia Pergolinion behalf of the Novara Atherosclerosis Study Group (NAS) ORIGINAL ARTICLE 11 February 2016 Pages: 143 - 150
Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary Intervention Igor MrdovicMirko ČolićJelena Marinkovic ORIGINAL ARTICLE 03 February 2016 Pages: 151 - 158
ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism Mauro ContiniElisa CompagninoPiergiuseppe Agostoni ORIGINAL ARTICLE 04 February 2016 Pages: 159 - 168
Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial Kevin LiouNigel JepsonSze-Yuan Ooi ORIGINAL ARTICLE 27 January 2016 Pages: 169 - 175
Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials Kwadwo Osei BonsuDaniel Diamond ReidpathAmudha Kadirvelu REVIEW ARTICLE 18 January 2016 Pages: 177 - 188
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials Vu HoangMahboob AlamYochai Birnbaum ORIGINAL ARTICLE 09 February 2016 Pages: 189 - 198
Erratum to: Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials Vu HoangMahboob AlamYochai Birnbaum Erratum 12 March 2016 Pages: 199 - 199
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants João MoraisRaffaele De Caterina REVIEW ARTICLE Open access 18 January 2016 Pages: 201 - 214
Contrast-Induced Acute Kidney Injury: An Update George ChalikiasIoannis DrososDimitrios N. Tziakas REVIEW ARTICLE 16 January 2016 Pages: 215 - 228
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation Michael V. CohenXi-Ming YangJames M. Downey SHORT COMMUNICATION 18 January 2016 Pages: 229 - 232
